Yan et al evaluated the impact of the transradial approach (TRA) on the vasodilatory function of the radial artery when utilized for cardiac catheterization, including coronary angiography and percutaneous coronary intervention (PCI). 1 The right radial artery (RRA) baseline diameter and response to flow-mediated dilation (FMD) and nitroglycerine-mediated dilation (NMD) were measured on day 1 and at 3 months after the TRA procedures. The FMD of the RRA decreased from 11.5% before the procedure to 4.1% (P < .05) on day 1 postprocedure and remained decreased at 0.7% (P < .01) at 3 months after the procedure. The NMD of the RRA decreased from 17.6% before the procedure to 5.4% (P < .05) on day 1 postprocedure and to 6.3% (P < .05) 3 months afterward. As discussed by the authors, 1 catheterization procedures via TRA decrease the radial artery FMD and NMD, resulting in immediate and persistent blunting of vasodilatory function of the radial artery. Three months later, the FMD and NMD were still decreased compared to before the procedure. The TRA impairs not only endothelial-dependent vasodilation but also endothelialindependent (vascular smooth muscle dependent) vasodilation, indicated by the decrease in FMD and NMD, respectively. Therefore, the authors 1 concluded that patients catheterized by TRA should have radial artery structure and function evaluated before any plan to use the artery as a coronary artery bypass graft (CABG).
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Yan et al, 2 in an earlier study, showed that coronary procedures via TRA can lead to increased RRA intima-media thickness (IMT) and a decrease in RRA diameter early after the procedure. A subsequent significant recovery in IMT occurred but there was no return to baseline. 2 The mean IMT of the RRA increased from 0.25 + 0.12 mm before the procedure to 0.69 + 0.31 mm 1 day following the procedure (P < .01) and to 0.38 + 0.17 mm 1 month later (P < .05). The decrease in mean RRA diameter followed a similar pattern. There was no RRA stenosis or occlusion before the TRA procedures. However, the incidence of RRA stenosis was 15.7% 1 day following the procedure and 7.6% 1 month later (P < .05 compared to 1 day following the procedures). The incidence of RRA occlusion was 0%, 2.8%, and 1.7%, respectively. 2 Paraskevas et al commented in a subsequent editorial that the TRA is not always a benign procedure and can be associated with short-and long-term effects that may compromise the RRA luminal wall. 3 Furthermore, they emphasized that repetitive RRA catheterizations may exacerbate the procedural problems resulting in failure to recover from the injury. Paraskevas et al even suggested the potential importance of trials involving routine preprocedural use of statins, which might suppress vascular hyperplasia, improve arterial IMT, reduce high-sensitivity C-reactive protein levels, and maximally improve the function of the endothelium. 3 The TRA has also been evaluated in patients with previous CABG surgery. Han et al evaluated 124 consecutive patients with a history of CABG surgery who underwent graft angiography and intervention via the TRA (n ¼ 68) or the transfemoral approach (TFA; n ¼ 56). 4 Between the 2 groups, no significant differences (P < .05) were observed in procedure time, puncture success rate, angiography, interventional procedure performance, major adverse cardiac events, or cerebrovascular events while hospitalized. However, vascular access site complications were significantly lower (P ¼ .021) and hospitalizations were shorter (P ¼ .007) with the TRA. They concluded that the TRA for CABG angiography and intervention is feasible and safe.
Advantages of TRA Versus TFA
There appears to be comparable procedural success using the TRA; and at the same time, this is associated with fewer access site complications such as hemorrhage. [5] [6] [7] [8] Bleeding is reduced after PCI, even in patients treated with aggressive antithrombotic regimens, including abciximab. 5 Also observed with TRA are more rapid mobilization of the patient, shorter hospital stays, 6 and reduced costs. 7 Many patients appear to prefer TRA over TFA. Use of TRA in PCI appears to have advantages both in unstable patients with acute coronary syndromes and in elective cases. Use of TRA appears to result in a significant decrease in procedural-associated morbidity 8 in extremely obese patients with a body mass index 40 kg/m 2 . In the setting of acute ST-segment elevation myocardial infarction without cardiogenic shock, PCI by TRA appears safe with comparable outcomes compared to TFA, while at the same time decreasing the risk of vascular complications. 9 Disadvantages of TRA Versus TFA Cardiac catheterization by the TRA induces significant histological changes suggestive of radial artery injury in association with the puncture site. 10 This injury is in the form of intimal hyperplasia, inflammation of the media, and tissue necrosis. However, there is insufficient data on the impact of PCI carried out by TFA regarding vasodilatory function of the femoral artery, femoral IMT, femoral artery diameter, and histological changes in the femoral artery. Further study of such changes is essential in order to make a more objective comparison between TRA and TFA.
The use of TRA is not appropriate in patients with a positive Allen test, indicating ulnar artery insufficiency with initial ulnar and radial artery occlusion followed by ulnar artery release or in procedures 7 that require a catheter larger than 6F. Radial artery spasm is another problem that can limit the ability to successfully complete PCI. Spasm appears more common in patients with peripheral arterial disease and in patients with hypertension not treated with calcium channel blockers prior to PCI. 11 When significant, spasm can result in longer procedure times. 6 There also appears to be a longer operator learning curve for the TRA, and the success of the TRA for PCI is quite dependent on operator experience. 12 In summary, significant reasons for crossover from the TRA to the TFA, the international standard of which varies from 3% to 8%, are a positive (abnormal) Allen test, severe RRA spasm, severe RRA tortuosity, and anatomical variations in the RRA. 13 Overcoming the Shortcomings of the TRA Appropriate patient selection indicates that a TRA cardiac catheterization should not be performed in patients with an abnormal Allen test due to its indication of incomplete palmar arch flow. 14 The use of smaller catheters such as 4F for PCI makes the TRA more feasible. 15, 16 Ball et al, in a study to characterize an operator learning curve for the TRA, showed that successful performance of PCI via the TRA depends on operator experience, including a total volume of more than 50 cases, in order to achieve outcomes comparable to experienced operators. 12 As an option, the ipsilateral ulnar artery can be cannulated if there is failure to engage the radial artery of the same arm. This reduces the crossover rate from arm to groin. 13 When it occurs, severe radial artery spasm can be managed successfully by additional bolus doses of a routine vasodilatory cocktail of glyceryl trinitrate 200 mcg and verapamil 2.5 mg. 13 The problem of significant vessel tortuosity can be overcome by exchange guidewires that offer extra support. 13 The use of a sheathless guiding catheter was usually feasible in most clinical settings in patients with small radial artery diameters (<2.3 mm), regardless of lesion complexity or severity. 17 
Conclusions
The use of the radial artery in cardiac catheterization is now very much in vogue. There are some technical problems to be aware of, many of which can be overcome with experience. Yan et al 1 have described another consideration in the use of this technique regarding subsequent use of a previously catheterized radial artery as a CABG. In this case, it appears advisable to assess radial artery structure and function before using it as a graft to eliminate functionally damaged radial arteries. Certainly, the availability of this technique adds to the options available to the interventional cardiologist, but he or she must be aware of the potential problems in each clinical situation.
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